Piper Sandler Downgrades $ELF to Neutral from Overweight, Lowers PT to $100 from $150 Analyst comments: "While strong momentum at rhode is continuing (40% growth expected in FY26, strength across categories), 3-4% sales growth implied for core ELF in FY26 is disappointing and not deserving of a premium multiple, in our view, considering resilience of the category (improved to +2% vs. -1% in F1Q26), easing comparisons, comments about strength in innovation and struggling competitive set in mass. Profitability is also resetting, with EBITDA margin guided for a 200+ bps decline, with lack of clarity on further investment cycle that may be necessary at rhode. Stock is under pressure after hours but is still pricey at 32x FY26 guide (and 30x our FY27 est.)--while rhode sales could see upside this year (Sephora UK launches next week), in absence of the core business rebounding beyond MSD, we think the multiple could re-rate lower." Analyst: Anna Andreeva